XML 33 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
(LOSS) EARNINGS PER SHARE
 9 Months Ended
Sep. 30, 2018
Earnings Per Share [Abstract]  
(LOSS) EARNINGS PER SHARE
(LOSS) EARNINGS PER SHARE
(Loss) earnings per share attributable to Bausch Health Companies Inc. were calculated as follows:
 
Three Months Ended
September 30,
 
Nine Months Ended
September 30,
(in millions, except per share amounts)
2018
 
2017
 
2018
 
2017
Net (loss) income attributable to Bausch Health Companies Inc.
$
(350
)
 
$
1,301

 
$
(3,804
)
 
$
1,891

 
 
 
 
 
 
 
 
Basic weighted-average common shares outstanding
351.5

 
350.4

 
351.1

 
350.1

Diluted effect of stock options and RSUs
—

 
1.9

 
—

 
1.3

Diluted weighted-average common shares outstanding
351.5

 
352.3

 
351.1

 
351.4

 
 
 
 
 
 
 
 
(Loss) earnings per share attributable to Bausch Health Companies Inc.:
 
 
 
 
 
 
 
Basic
$
(1.00
)
 
$
3.71

 
$
(10.83
)
 
$
5.40

Diluted
$
(1.00
)
 
$
3.69

 
$
(10.83
)
 
$
5.38


During the three and nine months ended September 30, 2018, all potential common shares issuable for stock options and RSUs were excluded from the calculation of diluted loss per share, as the effect of including them would have been anti-dilutive. The dilutive effect of potential common shares issuable for stock options and RSUs on the weighted-average number of common shares outstanding would have been as follows:
 
Three Months Ended
September 30, 2018
 
Nine Months Ended
September 30, 2018
(in millions)
 
Basic weighted-average common shares outstanding
351.5

 
351.1

Diluted effect of stock options and RSUs
4.2

 
3.4

Diluted weighted-average common shares outstanding
355.7

 
354.5

During the three and nine months ended September 30, 2018, time-based RSUs, performance-based RSUs and stock options to purchase approximately 3,750,000 and 3,979,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method. During the three and nine months ended September 30, 2017, time-based RSUs, performance-based RSUs and stock options to purchase approximately 7,601,000 and 7,601,000 common shares, respectively, were not included in the computation of diluted earnings per share because the effect would have been anti-dilutive under the treasury stock method.